6885 — BRIM Biotechnology Share Price
0.000.00%
Last trade - 00:00- TWD3.08bn
- TWD1.24bn
- TWD0.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.5 | ||
| Price to Tang. Book | 1.96 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 140,128.32 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -16.74% | ||
| Return on Equity | -16.64% | ||
| Operating Margin | -1567204.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 90.77 | 0.36 | 0.53 | 0.09 | 0.02 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BRIM Biotechnology Inc is a Taiwan-based company mainly engaged in drug discovery and development. The Company's product line is based on the pigment epithelium-derived factor (PEDF) and its derived short-chain polypeptide technology platform for multiple therapeutic areas and indications. The Company has four product candidates, BRM421 Dry Eye, BRM423 Severe Corneal Injury, BRM424 Neurotrophic Keratitis and BRM521 Degenerative Arthritis. BRM421 is primarily indicated for the treatment and repair of dry eye disease (DES) with corneal damage.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 31st, 2013
- Public Since
- June 23rd, 2022
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 132,310,000
- Address
- 2F, TAIPEI, 114
- Web
- https://www.brimbiotech.com/
- Phone
- +886 226598586
- Contact
- Mei-Hui Kuo
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 6885
Similar to 6885
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
Caliway Biopharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
Chunghwa Chemical Synthesis & Biotech Co
Taiwan Stock Exchange
FAQ
What is the BRIM Biotechnology share price?
As of Today at 19:41 UTC, shares in BRIM Biotechnology are trading at TWD23.30. This share price information is delayed by 15 minutes.
How has the BRIM Biotechnology share price performed this year?
Shares in BRIM Biotechnology last closed at TWD23.30 and the price had moved by -30.24% over the past 365 days. In terms of relative price strength the BRIM Biotechnology share price has underperformed the FTSE Developed Asia Pacific Index by -29.44% over the past year.
What are the analyst and broker recommendations for BRIM Biotechnology?
There is no consensus recommendation for this security.
Find out moreWhat is the BRIM Biotechnology dividend yield?
BRIM Biotechnology does not currently pay a dividend.
Does BRIM Biotechnology pay a dividend?
BRIM Biotechnology does not currently pay a dividend.
When does BRIM Biotechnology next pay dividends?
BRIM Biotechnology does not currently pay a dividend.
How do I buy BRIM Biotechnology shares?
To buy shares in BRIM Biotechnology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BRIM Biotechnology?
As of the previous close price of TWD23.30, shares in BRIM Biotechnology had a market capitalisation of TWD3.08bn.
Where are BRIM Biotechnology shares listed?
Here are the trading details for BRIM Biotechnology:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6885
What kind of share is BRIM Biotechnology?
Based on an overall assessment of its quality, value and momentum BRIM Biotechnology is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BRIM Biotechnology share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the BRIM Biotechnology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BRIM Biotechnology. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -43.7%.
As of the last closing price of TWD23.30, shares in BRIM Biotechnology were trading -38.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BRIM Biotechnology PE Ratio?
The BRIM Biotechnology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD23.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BRIM Biotechnology?
We do not have data on BRIM Biotechnology's directors